Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2017

Open Access 01-12-2017 | Research

Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study

Authors: Vesna Šuljagić, Ivan Miljković, Srđan Starčević, Nenad Stepić, Zoran Kostić, Dragutin Jovanović, Jelena Brusić-Renaud, Biljana Mijović, Sandra Šipetić-Grujičić

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Login to get access

Abstract

Background

The objective of this study was to investigate independent risk factors (RFs) connected with healthcare-associated (HA) Clostridium difficile infection (CDI) in surgical patients, its frequency per surgical wards and in-hospital-mortality at a single hospital.

Methods

Risk factors for the infection were prospectively assessed among surgical patients with laboratory confirmed HA CDI and compared with a control group without HA CDI.

Results

The overall incidence rate of HA CDI was 2.6 per 10000 patient-days. Significant independent RFs for HA CDI were the use of carbapenems (P = 0.007, OR: 10.62, 95% CI: 1.93–58.4), the admission to intensive care unit (P = 0.004, OR:3.00, 95% CI:1.41–6.40), and the administration of 3rd generation cephalosporins (P = 0.014, OR:2.27, 95% CI:1.18–4.39). Patients with HA CDI had significantly higher in–hospital mortality compared to controls (P: 0.007; OR: 8.95; 95% CI: 1.84–43.43).

Conclusions

CDI is an important HA infection in population of surgical patients and this study emphasizes the importance of the wise use of antibiotics, and other infection control strategies in order to prevent HA CDI, and to decrease the incidence and in-hospital mortality rate.
Literature
1.
go back to reference Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23:529–49.CrossRefPubMedPubMedCentral Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23:529–49.CrossRefPubMedPubMedCentral
2.
go back to reference Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009–2011. Am J Infect Control. 2015;43(11):1148–53.CrossRefPubMed Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009–2011. Am J Infect Control. 2015;43(11):1148–53.CrossRefPubMed
3.
go back to reference Stojanović P. Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients. Braz J Microbiol. 2016;47(4):902–10.CrossRef Stojanović P. Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients. Braz J Microbiol. 2016;47(4):902–10.CrossRef
4.
go back to reference Cho SM, Lee JJ, Yoon HJ. Clinical risk factors for Clostridium difficile-associated diseases. Braz J Infect Dis. 2012;16:256–61.CrossRefPubMed Cho SM, Lee JJ, Yoon HJ. Clinical risk factors for Clostridium difficile-associated diseases. Braz J Infect Dis. 2012;16:256–61.CrossRefPubMed
5.
go back to reference Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34.CrossRefPubMed Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34.CrossRefPubMed
6.
go back to reference Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14:1208–19.CrossRefPubMed Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14:1208–19.CrossRefPubMed
7.
go back to reference Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, ECDIS Study Group, et al. Clostridium difficile infectioninEurope: a hospital-based survey. Lancet. 2011;377:63–73.CrossRefPubMed Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, ECDIS Study Group, et al. Clostridium difficile infectioninEurope: a hospital-based survey. Lancet. 2011;377:63–73.CrossRefPubMed
8.
go back to reference Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W. Analysis of Morbidity and Mortality Outcomes in Postoperative Clostridium difficile Infection in the Veterans Health Administration. JAMA Surg. 2015;25:1–9. Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W. Analysis of Morbidity and Mortality Outcomes in Postoperative Clostridium difficile Infection in the Veterans Health Administration. JAMA Surg. 2015;25:1–9.
9.
go back to reference Rodrigues MA, Brady RR, Rodrigues J, Graham C, Gibb AP. Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg. 2010;8:368–72.CrossRefPubMed Rodrigues MA, Brady RR, Rodrigues J, Graham C, Gibb AP. Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg. 2010;8:368–72.CrossRefPubMed
10.
go back to reference Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL, et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2015;36:40–6.CrossRefPubMedPubMedCentral Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL, et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2015;36:40–6.CrossRefPubMedPubMedCentral
11.
go back to reference Šuljagić V, Đorđević D, Lazić S, Mijović B. Epidemiological characteristics of nosocomial diarrhea caused by Clostridium difficile in a tertiary level hospital in Serbia. Srp Arh Celok Lek. 2013;141:482–9.CrossRefPubMed Šuljagić V, Đorđević D, Lazić S, Mijović B. Epidemiological characteristics of nosocomial diarrhea caused by Clostridium difficile in a tertiary level hospital in Serbia. Srp Arh Celok Lek. 2013;141:482–9.CrossRefPubMed
12.
go back to reference Skovrlj B, Guzman JZ, Silvestre J, Al Maaieh M, Quereshi SA. Clostridium difficile colitis in patients undergoing lumbar spine surgery. Spine. 2014;39:E1167–1173.CrossRefPubMed Skovrlj B, Guzman JZ, Silvestre J, Al Maaieh M, Quereshi SA. Clostridium difficile colitis in patients undergoing lumbar spine surgery. Spine. 2014;39:E1167–1173.CrossRefPubMed
14.
go back to reference Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254–60.CrossRefPubMed Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254–60.CrossRefPubMed
15.
go back to reference Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infectious Diseases. 2017 Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infectious Diseases. 2017
16.
go back to reference Metzger R, Swenson BR, Bonatti H, Hedrick TL, Hranjec T, Popovsky KA, et al. Identification of risk factors for the development of Clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg. 2010;251(4):722–7.CrossRefPubMedPubMedCentral Metzger R, Swenson BR, Bonatti H, Hedrick TL, Hranjec T, Popovsky KA, et al. Identification of risk factors for the development of Clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg. 2010;251(4):722–7.CrossRefPubMedPubMedCentral
18.
go back to reference Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–9.CrossRefPubMed Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–9.CrossRefPubMed
19.
go back to reference Hung YP, Ko WC, Chou PH, Chen YH, Lin HJ, Liu YH, et al. Proton pump inhibitor exposure aggravates Clostridium difficile associated colitis: evidences from a mouse model. J Infect Dis. 2015;212:654–63.CrossRefPubMed Hung YP, Ko WC, Chou PH, Chen YH, Lin HJ, Liu YH, et al. Proton pump inhibitor exposure aggravates Clostridium difficile associated colitis: evidences from a mouse model. J Infect Dis. 2015;212:654–63.CrossRefPubMed
20.
go back to reference Williams C. Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol. 2001;15(3):511–21.CrossRefPubMed Williams C. Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol. 2001;15(3):511–21.CrossRefPubMed
21.
go back to reference Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One. 2014;9(6):e98400.CrossRefPubMedPubMedCentral Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One. 2014;9(6):e98400.CrossRefPubMedPubMedCentral
22.
go back to reference Rupnik M, Andrasevic AT, Dokic ET, Matas I, Jovanovic M, Pasic S, et al. Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe. 2016;42:142–4.CrossRefPubMed Rupnik M, Andrasevic AT, Dokic ET, Matas I, Jovanovic M, Pasic S, et al. Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe. 2016;42:142–4.CrossRefPubMed
23.
go back to reference Shin S, Kim M, Kim M, Lim H, Kim H, Lee K, et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med. 2012;32:355e8. Shin S, Kim M, Kim M, Lim H, Kim H, Lee K, et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med. 2012;32:355e8.
24.
go back to reference Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol. 2010;48:606e8.CrossRef Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol. 2010;48:606e8.CrossRef
25.
go back to reference Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22:S63–81.CrossRefPubMed Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22:S63–81.CrossRefPubMed
Metadata
Title
Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study
Authors
Vesna Šuljagić
Ivan Miljković
Srđan Starčević
Nenad Stepić
Zoran Kostić
Dragutin Jovanović
Jelena Brusić-Renaud
Biljana Mijović
Sandra Šipetić-Grujičić
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-017-0188-x

Other articles of this Issue 1/2017

Antimicrobial Resistance & Infection Control 1/2017 Go to the issue